Letko Brosseau & Associates Inc. lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 13.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 56,900 shares of the exchange traded fund’s stock after selling 8,900 shares during the quarter. Letko Brosseau & Associates Inc. owned about 0.07% of SPDR S&P Biotech ETF worth $5,275,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in XBI. ICA Group Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $27,000. Scarborough Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $32,000. BOCHK Asset Management Ltd purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $36,000. ORG Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $40,000. Finally, Vima LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $45,000.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA XBI traded down $1.56 during trading on Friday, reaching $96.52. The stock had a trading volume of 8,019,337 shares, compared to its average volume of 9,875,957. The company has a market cap of $7.36 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The business’s 50-day moving average price is $97.74 and its 200-day moving average price is $93.80.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- What is a Stock Market Index and How Do You Use Them?
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Using the MarketBeat Dividend Tax Calculator
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Stock Analyst Ratings and Canadian Analyst Ratings
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.